Register Financial Advisors LLC grew its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 5,365.6% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,832 shares of the company’s stock after purchasing an additional 6,707 shares during the period. Register Financial Advisors LLC’s holdings in BlackRock Health Sciences Term Trust were worth $105,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in BMEZ. Karpus Management Inc. lifted its stake in BlackRock Health Sciences Term Trust by 27.1% during the fourth quarter. Karpus Management Inc. now owns 1,217,589 shares of the company’s stock valued at $17,838,000 after buying an additional 259,464 shares in the last quarter. Wolverine Asset Management LLC lifted its stake in BlackRock Health Sciences Term Trust by 260.3% during the fourth quarter. Wolverine Asset Management LLC now owns 274,318 shares of the company’s stock valued at $4,019,000 after buying an additional 198,177 shares in the last quarter. Weiss Asset Management LP purchased a new stake in BlackRock Health Sciences Term Trust during the fourth quarter valued at about $2,669,000. Lazard Asset Management LLC lifted its stake in BlackRock Health Sciences Term Trust by 24.3% during the first quarter. Lazard Asset Management LLC now owns 798,962 shares of the company’s stock valued at $13,094,000 after buying an additional 156,417 shares in the last quarter. Finally, Quantedge Capital Pte Ltd lifted its position in shares of BlackRock Health Sciences Term Trust by 47.5% in the fourth quarter. Quantedge Capital Pte Ltd now owns 375,026 shares of the company’s stock worth $5,494,000 after purchasing an additional 120,800 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
Shares of NYSE BMEZ traded up 0.02 during mid-day trading on Friday, reaching 15.85. The company had a trading volume of 172,600 shares, compared to its average volume of 296,643. BlackRock Health Sciences Term Trust has a 12-month low of 12.93 and a 12-month high of 16.59. The stock has a fifty day moving average of 15.45 and a two-hundred day moving average of 15.55.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Breakout Stocks: What They Are and How to Identify Them
- MarketBeat Week in Review – 8/5 – 8/9
- What is a Dividend King?
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Business Services Stocks Investing
- The Cannabis Sector: Profitability Takes Center Stage
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.